IRIS UniCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.272
EU - Europa 8.087
AS - Asia 7.229
SA - Sud America 1.402
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 226
OC - Oceania 33
AN - Antartide 1
Totale 28.632
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.960
SG - Singapore 3.371
DE - Germania 2.018
CN - Cina 1.717
BR - Brasile 1.122
SE - Svezia 1.105
IT - Italia 1.033
FR - Francia 925
PL - Polonia 783
UA - Ucraina 683
VN - Vietnam 606
IE - Irlanda 384
GB - Regno Unito 360
IN - India 318
ID - Indonesia 257
FI - Finlandia 239
RU - Federazione Russa 197
CA - Canada 164
HK - Hong Kong 160
TR - Turchia 137
JP - Giappone 127
BD - Bangladesh 116
AR - Argentina 104
BE - Belgio 89
IQ - Iraq 79
MX - Messico 77
ZA - Sudafrica 68
NL - Olanda 45
IR - Iran 40
VE - Venezuela 38
PK - Pakistan 37
SA - Arabia Saudita 36
EC - Ecuador 34
ES - Italia 34
CO - Colombia 32
AU - Australia 27
CI - Costa d'Avorio 27
MA - Marocco 27
AT - Austria 26
KR - Corea 25
CL - Cile 23
CH - Svizzera 19
JO - Giordania 19
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
EG - Egitto 16
KE - Kenya 16
LT - Lituania 16
RO - Romania 15
TN - Tunisia 15
IL - Israele 14
JM - Giamaica 14
NP - Nepal 14
PH - Filippine 14
UY - Uruguay 14
AZ - Azerbaigian 13
DZ - Algeria 13
PE - Perù 13
BO - Bolivia 12
CR - Costa Rica 12
EU - Europa 12
AE - Emirati Arabi Uniti 11
DK - Danimarca 11
GR - Grecia 11
AL - Albania 10
HN - Honduras 10
KG - Kirghizistan 10
PY - Paraguay 10
MY - Malesia 9
PT - Portogallo 9
TT - Trinidad e Tobago 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BG - Bulgaria 8
ET - Etiopia 8
LK - Sri Lanka 8
NO - Norvegia 8
PA - Panama 8
OM - Oman 7
SN - Senegal 7
TW - Taiwan 7
KH - Cambogia 6
LA - Repubblica Popolare Democratica del Laos 6
LB - Libano 6
LV - Lettonia 6
NG - Nigeria 6
TH - Thailandia 6
AM - Armenia 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
AO - Angola 4
EE - Estonia 4
GE - Georgia 4
KZ - Kazakistan 4
MM - Myanmar 4
NI - Nicaragua 4
SC - Seychelles 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
BA - Bosnia-Erzegovina 3
Totale 28.207
Salva come PNG Salva come JPEG
Città #
Singapore 1.748
Chandler 1.287
Ashburn 1.127
San Jose 815
Warsaw 630
Jacksonville 393
Ann Arbor 390
Dearborn 371
Dublin 366
San Mateo 318
Beijing 308
Wilmington 288
Fairfield 273
Nanjing 250
Woodbridge 238
Jakarta 234
New York 215
Los Angeles 205
Ho Chi Minh City 198
Lauterbourg 195
Houston 189
Seattle 181
Cattolica 178
Boston 177
Hanoi 163
Munich 154
Hong Kong 150
Lawrence 140
Dallas 129
Kraków 121
Milan 120
Hefei 107
Moscow 106
Rome 106
Chicago 103
Frankfurt am Main 101
The Dalles 99
Tokyo 98
São Paulo 97
Redwood City 92
Bremen 91
Marseille 86
Cambridge 84
Izmir 83
Brussels 82
Nürnberg 81
Nanchang 76
Santa Clara 76
Buffalo 68
Princeton 68
Kunming 61
Boardman 60
Helsinki 59
Lancaster 58
Orem 58
Norwalk 57
Pune 56
Mountain View 51
London 47
Guangzhou 46
Hebei 46
Montreal 43
Shenyang 43
Atlanta 41
Tianjin 39
Brooklyn 38
Shanghai 38
Toronto 37
University Park 37
Hangzhou 36
Paris 36
Denver 35
Phoenix 35
Redmond 35
Council Bluffs 34
San Francisco 34
Baghdad 33
Da Nang 33
Detroit 31
Falls Church 31
Johannesburg 30
Chennai 28
Jiaxing 27
Abidjan 26
Changsha 26
Nuremberg 26
Rio de Janeiro 25
Zhengzhou 24
Fremont 23
Stockholm 23
Brasília 22
Jinan 22
Belo Horizonte 21
Dhaka 21
Kent 21
Leawood 21
Seoul 21
Turku 21
Washington 21
Andover 20
Totale 15.012
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 445
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 444
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 360
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 352
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 346
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 320
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 308
Comprehensive review on intravertebral intraspinal, intrajoint, and intradiscal vacuum phenomenon: from anatomy and physiology to pathology 271
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 268
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 264
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 262
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 250
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 237
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 232
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 226
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 226
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 226
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 218
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 211
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 207
Septic sacroiliitis: an uncommon septic arthritis 206
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 205
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 202
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 202
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 199
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 199
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 198
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 196
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 193
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 193
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 187
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 186
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 185
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 185
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 184
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 183
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 182
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 181
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 179
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 176
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 174
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 174
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 171
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 169
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 169
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 169
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 167
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 167
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 167
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 166
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 165
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 163
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 162
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 161
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 161
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 160
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 160
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 157
Preliminary classification criteria for the cryoglobulinaemic vasculitis 156
Troponin in Stable Ischemic Heart Disease and Diabetes 153
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 151
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 149
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 148
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 148
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 146
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 146
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 143
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 143
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 143
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 143
Troponin in Stable Ischemic Heart Disease and Diabetes 143
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 141
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 140
New therapeutic effects of cilostazol in patients with ischemic disorders. 139
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 138
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 137
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 136
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 135
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 134
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 132
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 132
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 130
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 130
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 128
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 128
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 127
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 126
Immune-Guided Therapy of COVID-19 126
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 123
Artrite reumatoide. Terapia 123
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 123
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 123
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 122
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 122
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 121
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 121
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 119
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 117
Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy 117
Rheumatoid arthritis and Alzheimer's disease: genetic and epigenetic links in inflammatory regulation 116
Totale 18.094
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.712
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.742 0 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20253.291 73 93 294 118 323 87 75 165 526 293 633 611
2025/20268.740 1.516 288 485 871 1.513 467 1.622 390 518 609 254 207
2026/2027737 478 259 0 0 0 0 0 0 0 0 0 0
Totale 28.632